Gilead has sole rights to COVID-19 blockbuster Veklury, GAO concludes
Throughout the frantic response to the pandemic last year, drugmakers worldwide tested hundreds of potential treatments. Gilead’s antiviral remdesivir quickly rose to the top of treatment guidelines, and with the pandemic spiraling out of control, advocacy groups called on the U.S. government to step in and enforce patents against the company. The federal government, advocates pointed out, has supported research on the medicine over… Read More »